Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engaging patients, clinicians and health funders in weight management: the Counterweight Programme.
Counterweight Project Team; McQuigg M, Brown JE, Broom JI, Laws RA, Reckless JP, Noble PA, Kumar S, McCombie EL, Lean ME, Lyons GF, Mongia S, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N, Haslam DW, Ross HM, Hole DJ, Radziwonik S. Counterweight Project Team, et al. Among authors: finer n. Fam Pract. 2008 Dec;25 Suppl 1:i79-86. doi: 10.1093/fampra/cmn081. Epub 2008 Nov 27. Fam Pract. 2008. PMID: 19042914
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L; NN8022-1807 Investigators. Astrup A, et al. Among authors: finer n. Int J Obes (Lond). 2012 Jun;36(6):843-54. doi: 10.1038/ijo.2011.158. Epub 2011 Aug 16. Int J Obes (Lond). 2012. PMID: 21844879 Free PMC article. Clinical Trial.
Obesity.
Finer N. Finer N. Clin Med (Lond). 2003 Jan-Feb;3(1):23-7. doi: 10.7861/clinmedicine.3-1-23. Clin Med (Lond). 2003. PMID: 12617409 Free PMC article. No abstract available.
Drug interventions for the treatment of obesity in children and adolescents.
Mead E, Atkinson G, Richter B, Metzendorf MI, Baur L, Finer N, Corpeleijn E, O'Malley C, Ells LJ. Mead E, et al. Among authors: finer n. Cochrane Database Syst Rev. 2016 Nov 29;11(11):CD012436. doi: 10.1002/14651858.CD012436. Cochrane Database Syst Rev. 2016. PMID: 27899001 Free PMC article. Review.
Pharmacotherapy of obesity.
Finer N. Finer N. Best Pract Res Clin Endocrinol Metab. 2002 Dec;16(4):717-42. doi: 10.1053/beem.2002.0231. Best Pract Res Clin Endocrinol Metab. 2002. PMID: 12468417 Review.
Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial).
van Baak MA, van Mil E, Astrup AV, Finer N, Van Gaal LF, Hilsted J, Kopelman PG, Rössner S, James WP, Saris WH; STORM Study Group. van Baak MA, et al. Among authors: finer n. Am J Clin Nutr. 2003 Aug;78(2):209-14. doi: 10.1093/ajcn/78.2.209. Am J Clin Nutr. 2003. PMID: 12885699 Clinical Trial.
578 results